Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 3
1984 1
1986 1
1987 2
1988 3
1989 5
1990 2
1991 2
1992 2
1993 1
1994 2
1996 1
2011 1
2012 2
2013 3
2014 4
2015 6
2016 2
2020 1
2022 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Oxaliplatin for the treatment of ovarian cancer.
Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Bogliolo S, et al. Among authors: babilonti l. Expert Opin Investig Drugs. 2015;24(9):1275-86. doi: 10.1517/13543784.2015.1062874. Epub 2015 Jun 30. Expert Opin Investig Drugs. 2015. PMID: 26125301 Review.
Robotic single-site hysterectomy: two institutions' preliminary experience.
Bogliolo S, Mereu L, Cassani C, Gardella B, Zanellini F, Dominoni M, Babilonti L, Delpezzo C, Tateo S, Spinillo A. Bogliolo S, et al. Among authors: babilonti l. Int J Med Robot. 2015 Jun;11(2):159-65. doi: 10.1002/rcs.1613. Epub 2014 Sep 18. Int J Med Robot. 2015. PMID: 25231021
Robotic single-site surgery for female-to-male transsexuals: preliminary experience.
Bogliolo S, Cassani C, Babilonti L, Gardella B, Zanellini F, Dominoni M, Santamaria V, Nappi RE, Spinillo A. Bogliolo S, et al. Among authors: babilonti l. ScientificWorldJournal. 2014;2014:674579. doi: 10.1155/2014/674579. Epub 2014 Apr 10. ScientificWorldJournal. 2014. PMID: 24982976 Free PMC article.
Current opinion on bevacizumab on endometrial cancer treatment.
Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Bogliolo S, et al. Among authors: babilonti l. Expert Opin Biol Ther. 2015 Feb;15(2):299-307. doi: 10.1517/14712598.2015.995624. Epub 2014 Dec 24. Expert Opin Biol Ther. 2015. PMID: 25539414
Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis.
Sala P, Bogliolo S, Barra F, Fazio A, Maramai M, Cassani C, Gardella B, Babilonti L, Giannelli F, Mammoliti S, Spinillo A, Ferrero S, Valenzano Menada M, Costantini S, Bruzzi P, Marchiolè P. Sala P, et al. Among authors: babilonti l. J Invest Surg. 2022 Feb;35(2):308-314. doi: 10.1080/08941939.2020.1856239. Epub 2020 Dec 8. J Invest Surg. 2022. PMID: 33289585 Free article.
39 results